Big Gain For Ocugen, Inc.

Ocugen, Inc. (OCGN:NASDAQ) shot up at $0.81, representing a gain of 173.9%. On Mon 21 Dec 20, OCGN:NASDAQ touched a New 2-Week Intraday Low of $0.29. The stock appeared on our News Catalysts scanner on Tue 22 Dec 20 at 09:13 AM in the 'BIOTECH' category. From Mon 07 Dec 20, the stock recorded 20.00% Up Days and 18.18% Green Days

The stock spiked on Tue 01 Dec 20 at $0.39 with a volume of 42M+, and its share price has been moving sideways in recent weeks.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).